GROSSO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 285
EU - Europa 106
AS - Asia 82
Totale 473
Nazione #
US - Stati Uniti d'America 285
SE - Svezia 32
CN - Cina 31
SG - Singapore 22
IE - Irlanda 17
AT - Austria 11
FI - Finlandia 10
IT - Italia 10
KR - Corea 10
DE - Germania 7
FR - Francia 7
JP - Giappone 6
VN - Vietnam 4
SA - Arabia Saudita 3
TR - Turchia 3
BE - Belgio 2
GB - Regno Unito 2
IN - India 2
NL - Olanda 2
PL - Polonia 2
CH - Svizzera 1
ES - Italia 1
ID - Indonesia 1
LT - Lituania 1
UA - Ucraina 1
Totale 473
Città #
Chandler 43
Houston 18
Santa Clara 18
Dublin 17
Singapore 17
Fairfield 15
Ann Arbor 14
Beijing 13
Ashburn 12
Cambridge 11
Vienna 11
Woodbridge 10
Dearborn 9
Nyköping 8
Redwood City 8
Medford 7
Wilmington 6
Columbus 5
Falls Church 5
Princeton 5
Dong Ket 4
Pisa 4
Seattle 4
Boardman 3
Changsha 3
Guangzhou 3
Izmir 3
Menlo Park 3
Torino 3
Villeurbanne 3
Bloomington 2
Brussels 2
Grafing 2
Memphis 2
Milan 2
Shanghai 2
Warsaw 2
Amsterdam 1
Boston 1
Buffalo 1
Chicago 1
Fremont 1
Hebei 1
Hefei 1
Jacksonville 1
Jakarta 1
London 1
Los Angeles 1
Mountain View 1
New Haven 1
Nijmegen 1
Norwalk 1
Port Jefferson 1
San Diego 1
Shenzhen 1
Sunnyvale 1
Tappahannock 1
Tokyo 1
Zhengzhou 1
Zurich 1
Totale 322
Nome #
Eps8 involvement in neuregulin1-ErbB4 mediated migration in the neuronal progenitor cell line ST14A 176
TAB2 as a regulator of NCoR engagement at ERα target genes 90
Suppression of TAB2 protein reverts Tamoxifen resistance in breast cancer cells 80
Gene signature predictive of acquired resistance to hormone treatment in ER+ breast cancer 80
ErbB4 activity assays in a cell model following ErbB3 silencing 62
Totale 488
Categoria #
all - tutte 1.376
article - articoli 0
book - libri 0
conference - conferenze 736
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 3 15 10 5 8 3 3 2
2020/202155 6 4 2 3 8 5 4 2 8 2 3 8
2021/202264 4 2 4 2 1 5 5 2 2 2 18 17
2022/2023105 9 13 1 15 5 24 5 6 15 5 6 1
2023/202431 7 5 3 0 1 4 0 1 0 3 5 2
2024/202554 0 4 3 11 36 0 0 0 0 0 0 0
Totale 488